Menicon Co Ltd (MECNY) Stock

About Menicon Co Ltd

Menicon Co Ltd operates as a specialized manufacturer within the contact lens industry. Its operations involve the worldwide manufacturing, distribution, and trade (both export and import) of contact lenses, in addition to other medical merchandise. The company also produces and sells medical instruments, supplies various medical provisions, and is actively engaged in the research and development of intraocular lenses. Its diverse product portfolio prominently includes soft contact lenses, rigid gas permeable lenses, and a range of lens care products.

Menicon Co Ltd is headquartered in US.

Menicon Co Ltd (MECNY) stock trades at $88.63 with a market capitalization of $26.87B. The stock is valued at a price-to-earnings (P/E) ratio of 11440.55, price-to-book of 196.66, price-to-sales of 71.97. Over the past 52 weeks the stock has ranged between $88.63 and $88.63, and currently trades at its 52-week high.

On profitability, Menicon Co Ltd generates a return on equity (ROE) of 1.74%, return on capital employed of 7.50%, an operating margin of 20.30%, a net profit margin of 2.53%.

In its most recent fiscal year, Menicon Co Ltd reported annual revenue of $121.5B, net profit of $5.6B, revenue has compounded at 7.7% a year over the last five years, profit at 6.9% a year.

The balance sheet shows a debt-to-equity ratio of 0.89, a current ratio of 2.82, total assets of $187.3B, $42.0B in cash and equivalents.

MECNY has an average daily trading volume of 36.145 shares, a beta of 0.15 (less volatile than the overall market).

Official website: www.menicon.co.jp